4.7 Article

Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation

期刊

出版社

SHENYANG PHARMACEUTICAL UNIV
DOI: 10.1016/j.ajps.2023.100776

关键词

Aspirin; Transdermal drug delivery; Polymeric microneedles; Hydrolysis; Antiplatelet aggregation

向作者/读者索取更多资源

To reduce gastrointestinal mucosal damage caused by aspirin, a dissolvable polymeric microneedle (MN) patch loaded with aspirin was developed. The MNs, made of biodegradable polymers, puncture the skin and dissolve in the subcutaneous tissue, delivering a stable plasma concentration of aspirin through micropores created by the punctures. The stability of aspirin during MN fabrication was analyzed, and the hydrolysis rate of aspirin in the MNs was found to be less than 2%. Compared to oral administration, MN administration provides a smoother plasma concentration curve and requires a lower effective dose of antiplatelet aggregation. Aspirin-loaded MNs cause mild skin irritation and quickly recover within 24 hours.
To reduce mucosal damage in the gastrointestinal tract caused by aspirin, we developed a dissolvable polymeric microneedle (MN) patch loaded with aspirin. Biodegradable polymers provide mechanical strength to the MNs. The MN tips punctured the cuticle of the skin and dissolved when in contact with the subcutaneous tissue. The aspirin in the MN patch is delivered continuously through an array of micropores created by the punctures, providing a stable plasma concentration of aspirin. The factors affecting the stability of aspirin during MNs fabrication were comprehensively analyzed, and the hydrolysis rate of aspirin in the MNs was less than 2%. Compared to oral administration, MN administration not only had a smoother plasma concentration curve but also resulted in a lower effective dose of antiplatelet aggregation. Aspirin-loaded MNs were mildly irritating to the skin, causing only slight erythema on the skin and recovery within 24 h. In summary, aspirin-loaded MNs provide a new method to reduce gastrointestinal adverse effects in patients requiring aspirin regularly.(c) 2023 Published by Elsevier B.V. on behalf of Shenyang Pharmaceutical University. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据